Clik here to view.
ANR 2010: MIBG avidity, tandem transplant (Korea), and ch14.18 (Germany) updates
MIBG non-avid at diagnosis = better outcome? POC39 (p. 211) Neuroblastomas with non-avid I-123 MIBG scan and negative urinary catecholamine secretion: A single institute’s experience PL30 (p. 102)...
View ArticleCNCF 2010 ~ Dr Peter Zage on 3F8 phase II randomized trial
Dr Peter Zage from MD Anderson in Houston TX gave a presentation at the Children’s Neuroblastoma Cancer Foundation (CNCF) conference Saturday July 10, 2010 on the 3F8 randomized trial: A Study of...
View ArticleNew frontline high-risk neuroblastoma trial includes MIBG transplant
Pilot study: 131I-MIBG radiotherapy with chemotherapy after induction for newly diagnosed Dr Greg Yanik (University of Michigan) presented preliminary results of the NANT (New Approaches to...
View ArticleClik here to view.
Biggest news for neuroblastoma in a decade: ch14.18 plus GM-CSF and IL2
Rare news A disease that afflicts only 350 children per year in the US (in the high-risk form) does not make headlines very often. But after the September 30, 2010 publication of the New England...
View ArticleClik here to view.
Antibodies and other bits
Big antibody news The “third generation” humanized anti-GD2 antibody with protein fusion of IL2 to the antibody has completed Phase I and II clinical trials for melanoma and neuroblastoma, and is now...
View Article
